Page last updated: 2024-08-25

chitosan and Acute Kidney Injury

chitosan has been researched along with Acute Kidney Injury in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's4 (28.57)24.3611
2020's9 (64.29)2.80

Authors

AuthorsStudies
Boesen, EI; Chhonker, YS; Ding, L; Dsouza, DL; Foster, KW; Jang, HS; Jensen-Smith, H; Jogdeo, CM; Murry, DJ; Oupický, D; Padanilam, B; Panja, S; Tang, S; Tang, W; Yu, A1
Bai, Y; Cheng, G; Du, B; Duan, S; Jiao, Q; Pang, M; Yu, L; Zhao, M1
Karnam, K; Krishna Venuganti, V; Kulkarni, OP; Mahale, A; Sedmaki, K; Sharma, P1
Casettari, L; El-Gogary, RI; Elmowafy, E; O El-Derany, M; Soliman, ME1
Alfaifi, MY; Alkabli, J; Elbehairi, SEI; Elshaarawy, RFM; Hassan, YA; Serag, WM; Shati, AA1
Dong, L; Fu, H; Li, M; Li, Y; Luo, J; Shi, F; Shu, G; Tang, H; Yan, Q; Ye, G; Yin, H; Zhang, W; Zhao, L; Zhao, X; Zhong, X1
Cao, Y; Dong, H; Dong, X; Gong, J; Han, B; Jin, S; Liu, J; Shi, W; Tan, X; Wang, Z; Xiang, F; Yin, S; Zhang, G; Zhang, N; Zhang, S; Zhao, X1
Wang, M1
Hu, JB; Hu, Y; Li, SJ; Li, YG; Liang, J; Tan, XY; Tan, Z; Wang, DW; Wang, JH; Zhao, YF1
Chen, X; Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Yu, H1
Cheema, MU; Frøkiær, J; Gao, S; Kjems, J; Nilsson, L; Nørregaard, R; Wang, Y; Yang, C1
Che, Y; Du, W; Feng, G; Gao, J; He, N; Kong, D; Li, Y; Li, Z; Liu, J; Liu, N; Nie, Y; Tao, H; Wang, R; Xu, Y; Zhang, J; Zhao, Q; Zhu, D1
Du, Z; Duan, C; Gao, J; Hao, T; Li, J; Liu, R; Liu, Z; Wang, C; Wang, Y; Wu, J; Zhou, J1
Im, SY; Kim, HW; Kim, YH; Lee, JH; Moon, ME; Park, HS; Yoon, HJ1

Other Studies

14 other study(ies) available for chitosan and Acute Kidney Injury

ArticleYear
Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury.
    Biomaterials, 2022, Volume: 285

    Topics: Acute Kidney Injury; Chitosan; Drug Carriers; Humans; Kidney; Reperfusion Injury; RNA, Small Interfering; Tumor Suppressor Protein p53

2022
Co-delivery of celastrol and lutein with pH sensitive nano micelles for treating acute kidney injury.
    Toxicology and applied pharmacology, 2022, 09-01, Volume: 450

    Topics: Acute Kidney Injury; Chitosan; Humans; Hydrogen-Ion Concentration; Lutein; Micelles; Pentacyclic Triterpenes

2022
HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy.
    International immunopharmacology, 2022, Volume: 112

    Topics: Acute Kidney Injury; Animals; Chitosan; Creatinine; Disease Models, Animal; Histone Deacetylases; Inflammasomes; Interleukin-1beta; Kruppel-Like Transcription Factors; Lipocalin-2; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Oxalates; RNA Interference; RNA, Small Interfering; Transcription Factors; Tumor Necrosis Factor-alpha

2022
Gamma oryzanol loaded into micelle-core/chitosan-shell: from translational nephroprotective potential to emphasis on sirtuin-1 associated machineries.
    International journal of pharmaceutics, 2023, Jan-25, Volume: 631

    Topics: Acute Kidney Injury; Animals; Chitosan; Micelles; Polyesters; Polyethylene Glycols; Rats; Sirtuins

2023
Comparison of the ameliorative roles of crab chitosan nanoparticles and mesenchymal stem cells against cisplatin-triggered nephrotoxicity.
    International journal of biological macromolecules, 2023, Jul-01, Volume: 242, Issue:Pt 4

    Topics: Acute Kidney Injury; Animals; Brachyura; Chitosan; Cisplatin; Fibrosis; Kidney; Male; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley

2023
Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin.
    International journal of biological macromolecules, 2023, Aug-01, Volume: 245

    Topics: Acute Kidney Injury; Chitosan; Cisplatin; Humans; Nanoparticles; Particle Size

2023
Chitosan oligosaccharide attenuates acute kidney injury and renal interstitial fibrosis induced by ischemia-reperfusion.
    Renal failure, 2023, Volume: 45, Issue:1

    Topics: Acute Kidney Injury; Chitosan; Fibrosis; Humans; Ischemia; Kidney; Oligosaccharides; Reperfusion; Reperfusion Injury

2023
KIM1: a gateway for tubule drug delivery.
    Nature reviews. Nephrology, 2020, Volume: 16, Issue:12

    Topics: Acute Kidney Injury; Chitosan; Humans; Kidney; Prodrugs; Reactive Oxygen Species

2020
Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury.
    Carbohydrate polymers, 2021, Mar-15, Volume: 256

    Topics: Acute Kidney Injury; Animals; Apoptosis; Buffers; Cell Line; Cell Survival; Chitosan; Drug Delivery Systems; Endocytosis; Epithelium; Humans; In Vitro Techniques; Inflammation; Kidney; Kidney Tubules; Low Density Lipoprotein Receptor-Related Protein-2; Lysosomes; Male; Mice; Mice, Inbred BALB C; Mitochondria; Oligosaccharides; Oxidative Stress; Polymers; Reactive Oxygen Species; Solubility; Spectrometry, Fluorescence

2021
Protective effect of sulfated chitosan of C3 sulfation on glycerol-induced acute renal failure in rat kidney.
    International journal of biological macromolecules, 2014, Volume: 65

    Topics: Acute Kidney Injury; Animals; Calcium; Chitosan; Cytoprotection; Female; Glycerol; Kidney; Male; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Structure-Activity Relationship

2014
Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.
    Theranostics, 2015, Volume: 5, Issue:2

    Topics: Acute Kidney Injury; Animals; Cell Line; Chitosan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Histocytochemistry; Immunohistochemistry; Macrophages; Male; Mice; Microscopy, Confocal; Nanoparticles; Optical Imaging; RNA, Small Interfering; Treatment Outcome; Ureteral Obstruction

2015
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
    Journal of the American Society of Nephrology : JASN, 2016, Volume: 27, Issue:8

    Topics: Acute Kidney Injury; Adipose Tissue; Animals; Chitosan; Combined Modality Therapy; Hydrogel, Polyethylene Glycol Dimethacrylate; Insulin-Like Growth Factor I; Mesenchymal Stem Cell Transplantation; Mice

2016
The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
    Biomaterials, 2012, Volume: 33, Issue:14

    Topics: Acute Kidney Injury; Adipose Tissue; Animals; Biocompatible Materials; Blood Urea Nitrogen; Cell Differentiation; Cell Survival; Chitosan; Creatinine; Genes, Reporter; Hydrogels; Male; Materials Testing; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Tissue Scaffolds; Transfection

2012
Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2008, Volume: 46, Issue:2

    Topics: Acute Kidney Injury; Animals; Chitosan; Dipeptidases; Glycerol; In Vitro Techniques; Kidney Tubules, Proximal; Nitric Oxide; Oligosaccharides; Rats; Solvents; Superoxide Dismutase; Tumor Necrosis Factors

2008